Annual Total Long Term Liabilities
$25.85 B
+$4.27 B+19.81%
31 December 2023
Summary:
Eli Lilly and Company annual total long term liabilities is currently $25.85 billion, with the most recent change of +$4.27 billion (+19.81%) on 31 December 2023. During the last 3 years, it has fallen by -$2.48 billion (-8.74%). LLY annual total long term liabilities is now -8.74% below its all-time high of $28.33 billion, reached on 31 December 2020.LLY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$36.61 B
+$5.49 B+17.66%
30 September 2024
Summary:
Eli Lilly and Company quarterly total long term liabilities is currently $36.61 billion, with the most recent change of +$5.49 billion (+17.66%) on 30 September 2024. Over the past year, it has increased by +$12.00 billion (+48.77%). LLY quarterly long term liabilities is now at all-time high.LLY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.8% | +48.8% |
| 3 y3 years | -8.7% | +37.9% |
| 5 y5 years | +22.4% | +55.1% |
LLY Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.7% | +19.8% | at high | +69.7% |
| 5 y | 5 years | -8.7% | +22.4% | at high | +69.7% |
| alltime | all time | -8.7% | +7171.3% | at high | >+9999.0% |
Eli Lilly And Company Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $36.61 B(+17.7%) |
| June 2024 | - | $31.12 B(-4.1%) |
| Mar 2024 | - | $32.45 B(+25.5%) |
| Dec 2023 | $25.85 B(+19.8%) | $25.85 B(+5.0%) |
| Sept 2023 | - | $24.61 B(-0.6%) |
| June 2023 | - | $24.75 B(-4.3%) |
| Mar 2023 | - | $25.86 B(+19.8%) |
| Dec 2022 | $21.58 B(-12.3%) | $21.58 B(-0.3%) |
| Sept 2022 | - | $21.64 B(-5.0%) |
| June 2022 | - | $22.78 B(-5.3%) |
| Mar 2022 | - | $24.07 B(-2.1%) |
| Dec 2021 | $24.60 B(-13.2%) | $24.60 B(-7.4%) |
| Sept 2021 | - | $26.55 B(+1.9%) |
| June 2021 | - | $26.05 B(-7.0%) |
| Mar 2021 | - | $28.02 B(-1.1%) |
| Dec 2020 | $28.33 B(+14.2%) | $28.33 B(+5.0%) |
| Sept 2020 | - | $26.97 B(+4.9%) |
| June 2020 | - | $25.71 B(+1.6%) |
| Mar 2020 | - | $25.30 B(+1.9%) |
| Dec 2019 | $24.81 B(+17.5%) | $24.81 B(+5.1%) |
| Sept 2019 | - | $23.60 B(-1.5%) |
| June 2019 | - | $23.95 B(-1.0%) |
| Mar 2019 | - | $24.21 B(+14.7%) |
| Dec 2018 | $21.11 B(+12.4%) | $21.11 B(+7.4%) |
| Sept 2018 | - | $19.65 B(+11.1%) |
| June 2018 | - | $17.68 B(-3.0%) |
| Mar 2018 | - | $18.22 B(-3.0%) |
| Dec 2017 | $18.78 B(+36.7%) | $18.78 B(+22.1%) |
| Sept 2017 | - | $15.38 B(-0.6%) |
| June 2017 | - | $15.48 B(+18.4%) |
| Mar 2017 | - | $13.07 B(-4.8%) |
| Dec 2016 | $13.74 B(+7.8%) | $13.74 B(+0.3%) |
| Sept 2016 | - | $13.70 B(+2.1%) |
| June 2016 | - | $13.42 B(+8.9%) |
| Mar 2016 | - | $12.32 B(-3.4%) |
| Dec 2015 | $12.75 B(+14.0%) | $12.75 B(-0.1%) |
| Sept 2015 | - | $12.76 B(-2.6%) |
| June 2015 | - | $13.10 B(+5.9%) |
| Mar 2015 | - | $12.36 B(+10.6%) |
| Dec 2014 | $11.18 B(+28.6%) | $11.18 B(+19.0%) |
| Sept 2014 | - | $9.39 B(-2.2%) |
| June 2014 | - | $9.61 B(-1.7%) |
| Mar 2014 | - | $9.78 B(+12.5%) |
| Dec 2013 | $8.69 B(-22.6%) | $8.69 B(-3.4%) |
| Sept 2013 | - | $8.99 B(-6.1%) |
| June 2013 | - | $9.58 B(-1.7%) |
| Mar 2013 | - | $9.75 B(-13.2%) |
| Dec 2012 | $11.24 B(+0.4%) | $11.24 B(-0.6%) |
| Sept 2012 | - | $11.30 B(+3.7%) |
| June 2012 | - | $10.89 B(+0.3%) |
| Mar 2012 | - | $10.86 B(-3.0%) |
| Dec 2011 | $11.19 B(-2.6%) | $11.19 B(+14.6%) |
| Sept 2011 | - | $9.77 B(-1.2%) |
| June 2011 | - | $9.88 B(-2.3%) |
| Mar 2011 | - | $10.11 B(-12.0%) |
| Dec 2010 | $11.49 B(+1.1%) | $11.49 B(+2.9%) |
| June 2010 | - | $11.16 B(+0.8%) |
| Mar 2010 | - | $11.08 B(-2.5%) |
| Dec 2009 | $11.37 B(+21.4%) | $11.37 B(+1.9%) |
| Sept 2009 | - | $11.16 B(-2.0%) |
| June 2009 | - | $11.38 B(-1.1%) |
| Mar 2009 | - | $11.51 B(+22.9%) |
| Dec 2008 | $9.37 B(+18.0%) | $9.37 B(+25.6%) |
| Sept 2008 | - | $7.46 B(-3.9%) |
| June 2008 | - | $7.76 B(-4.8%) |
| Mar 2008 | - | $8.15 B(+2.7%) |
| Dec 2007 | $7.93 B(+34.7%) | $7.93 B(-0.3%) |
| Sept 2007 | - | $7.96 B(+0.1%) |
| June 2007 | - | $7.95 B(-1.2%) |
| Mar 2007 | - | $8.05 B(+36.6%) |
| Dec 2006 | $5.89 B | $5.89 B(-15.6%) |
| Sept 2006 | - | $6.98 B(-11.3%) |
| June 2006 | - | $7.86 B(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2006 | - | $7.93 B(-1.8%) |
| Dec 2005 | $8.07 B(+27.1%) | $8.07 B(-3.1%) |
| Sept 2005 | - | $8.33 B(+24.5%) |
| June 2005 | - | $6.69 B(+6.8%) |
| Mar 2005 | - | $6.26 B(-1.5%) |
| Dec 2004 | $6.35 B(-0.1%) | $6.35 B(+0.3%) |
| Sept 2004 | - | $6.33 B(+14.1%) |
| June 2004 | - | $5.55 B(-11.8%) |
| Mar 2004 | - | $6.29 B(-1.1%) |
| Dec 2003 | $6.36 B(+11.5%) | $6.36 B(-4.0%) |
| Sept 2003 | - | $6.63 B(+3.6%) |
| June 2003 | - | $6.40 B(+0.9%) |
| Mar 2003 | - | $6.34 B(+11.1%) |
| Dec 2002 | $5.70 B(+38.2%) | $5.70 B(+1.1%) |
| Sept 2002 | - | $5.64 B(+19.7%) |
| June 2002 | - | $4.71 B(+4.1%) |
| Mar 2002 | - | $4.53 B(+9.7%) |
| Dec 2001 | $4.13 B(+12.1%) | $4.13 B(-2.8%) |
| Sept 2001 | - | $4.25 B(+8.4%) |
| June 2001 | - | $3.92 B(+6.2%) |
| Mar 2001 | - | $3.69 B(+0.2%) |
| Dec 2000 | $3.68 B(-5.0%) | $3.68 B(-3.8%) |
| Sept 2000 | - | $3.83 B(-2.4%) |
| June 2000 | - | $3.92 B(+2.9%) |
| Mar 2000 | - | $3.81 B(-1.7%) |
| Dec 1999 | $3.88 B(+8.9%) | $3.88 B(-9.4%) |
| Sept 1999 | - | $4.28 B(+28.4%) |
| June 1999 | - | $3.33 B(+2.6%) |
| Mar 1999 | - | $3.25 B(-8.8%) |
| Dec 1998 | $3.56 B(-0.6%) | $3.56 B(-8.9%) |
| Sept 1998 | - | $3.90 B(+7.9%) |
| June 1998 | - | $3.62 B(+1.6%) |
| Mar 1998 | - | $3.56 B(-0.5%) |
| Dec 1997 | $3.58 B(-10.2%) | $3.58 B(-5.3%) |
| Sept 1997 | - | $3.78 B(-3.5%) |
| June 1997 | - | $3.92 B(+0.9%) |
| Mar 1997 | - | $3.88 B(-2.6%) |
| Dec 1996 | $3.98 B(-0.7%) | $3.98 B(+4.0%) |
| Sept 1996 | - | $3.83 B(-0.4%) |
| June 1996 | - | $3.85 B(-0.8%) |
| Mar 1996 | - | $3.88 B(-3.4%) |
| Dec 1995 | $4.01 B(+15.2%) | $4.01 B(+16.3%) |
| Sept 1995 | - | $3.45 B(-0.6%) |
| June 1995 | - | $3.47 B(+15.8%) |
| Mar 1995 | - | $3.00 B(-14.0%) |
| Dec 1994 | $3.48 B(+63.7%) | $3.48 B(+41.0%) |
| Sept 1994 | - | $2.47 B(-0.4%) |
| June 1994 | - | $2.48 B(+15.6%) |
| Mar 1994 | - | $2.15 B(+0.9%) |
| Dec 1993 | $2.13 B(+53.9%) | $2.13 B(+14.1%) |
| Sept 1993 | - | $1.86 B(+12.3%) |
| June 1993 | - | $1.66 B(-0.6%) |
| Mar 1993 | - | $1.67 B(+20.8%) |
| Dec 1992 | $1.38 B(+30.3%) | $1.38 B(+2.0%) |
| Sept 1992 | - | $1.36 B(+20.0%) |
| June 1992 | - | $1.13 B(+5.0%) |
| Mar 1992 | - | $1.07 B(+1.4%) |
| Dec 1991 | $1.06 B(+23.6%) | $1.06 B(-5.0%) |
| Sept 1991 | - | $1.12 B(+25.8%) |
| June 1991 | - | $887.20 M(+9.2%) |
| Mar 1991 | - | $812.40 M(-5.3%) |
| Dec 1990 | $857.70 M(+12.5%) | $857.70 M(+8.4%) |
| Sept 1990 | - | $791.00 M(+0.2%) |
| June 1990 | - | $789.20 M(-0.9%) |
| Mar 1990 | - | $796.50 M(+4.5%) |
| Dec 1989 | $762.10 M(+1.8%) | $762.10 M(+8.1%) |
| Sept 1989 | - | $705.10 M(-3.5%) |
| June 1989 | - | $730.60 M(-2.4%) |
| Dec 1988 | $748.60 M(-2.0%) | $748.60 M(-2.0%) |
| Dec 1987 | $764.10 M(+10.1%) | $764.10 M(+10.1%) |
| Dec 1986 | $693.70 M(+33.4%) | $693.70 M(+33.4%) |
| Dec 1985 | $520.20 M(+46.3%) | $520.20 M(+46.3%) |
| Dec 1984 | $355.50 M | $355.50 M |
FAQ
- What is Eli Lilly and Company annual total long term liabilities?
- What is the all time high annual total long term liabilities for Eli Lilly and Company?
- What is Eli Lilly and Company annual total long term liabilities year-on-year change?
- What is Eli Lilly and Company quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly long term liabilities year-on-year change?
What is Eli Lilly and Company annual total long term liabilities?
The current annual total long term liabilities of LLY is $25.85 B
What is the all time high annual total long term liabilities for Eli Lilly and Company?
Eli Lilly and Company all-time high annual total long term liabilities is $28.33 B
What is Eli Lilly and Company annual total long term liabilities year-on-year change?
Over the past year, LLY annual total long term liabilities has changed by +$4.27 B (+19.81%)
What is Eli Lilly and Company quarterly total long term liabilities?
The current quarterly long term liabilities of LLY is $36.61 B
What is the all time high quarterly long term liabilities for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly total long term liabilities is $36.61 B
What is Eli Lilly and Company quarterly long term liabilities year-on-year change?
Over the past year, LLY quarterly total long term liabilities has changed by +$12.00 B (+48.77%)